Clinical Trials Logo

Clinical Trial Summary

In recent years, frozen-thawed embryo transfer procedure (FET) has been widely used to increase the cumulative pregnancy rate per IVF-cycle: which is the best preparation protocol remains a matter of debate.

A retrospective analysis was conducted between 2012-2017. The aim was comparing clinical pregnancy rate (CPR) of pure natural cycle frozen-thawed embryo transfer (NC-FET) versus natural cycle frozen-thawed embryo transfer with hCG-triggered ovulation (mNC-FET).


Clinical Trial Description

Compared to repeated oocyte retrieval procedure, frozen-thawed embryo transfer (FET) has been widely used to increase the cumulative pregnancy rate per IVF-cycle, with demonstrated superiority in preventing ovarian hyperstimulation syndrome and improving cost-efficiency and time to pregnancy.

It is controversial whether triggering ovulation of the dominant follicle using human chorionic gonadotrophin (hCG) may benefit or reduce embryo implantation, when compared with a natural cycle environment. Unfavourable clinical outcomes of controlled ovarian stimulation have been reported by recently published studies, compared to the spontaneous LH surge.

This study aimed to compare the effectiveness in terms of better clinical pregnancy rates (CPR) of pure natural cycle frozen-thawed embryo transfer (NC-FET) versus natural cycle frozen-thawed embryo transfer modified by HCG administration\with hCG-triggered ovulation (mNC-FET).

A retrospective analysis was conducted between 2012-2017. In patients with regular ovulatory cycles, the timing of embryo thawing and transferring was based on spontaneous LH surge (NC-FET). Patients attended for ultrasound evaluation of the dominant follicle from Day 8 to 10 of their menstrual cycle (depending on cycle length), detecting luteinizing hormone (LH) surge in urine/ taking an ovulation test for urinary LH measurement. In selected cases, a serum assays of LH, progesterone and estradioI has been further obtained. When the endometrial thickness reached 8 mm and dominant follicle 16-20 mm in diameter, hCG was administered in absence of urinary LH surge. Embryo thawing and transfer was planned 7 days after LH surge or HCG administration, whether G5 or G6 blastocyst. Exogenous progesterone supplementation started 2 days after hCG administration versus the same day of embryo transfer procedure in NC- ET. To limit potential confounders, only single blastocyst transfer cycles were included, vitrified on Days 5 or 6, excluding PGT-a (Pre Gestational Test for aneuploydia) cycles and cleavage stage embryo transfers. A unilevel and multi level logistic regression analysis was conducted using Stata Software versione15. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03581422
Study type Observational
Source Istituto Clinico Humanitas
Contact
Status Completed
Phase
Start date January 1, 2012
Completion date December 31, 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03642665 - Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer Phase 4
Completed NCT01919502 - Semi-quantitative Pregnancy Test to Monitor hCG Levels After Assisted Fertility Treatment N/A
Completed NCT03292770 - Mucus Removal Before Embryo Transfer N/A
Recruiting NCT06134609 - Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer? N/A
Completed NCT03040830 - Effect of Timing Progesterone Luteal Support on Embryo Transfer Phase 4
Recruiting NCT04725864 - Progesterone as Luteal Support in Frozen IVF Natural Cycles Phase 4
Recruiting NCT04619524 - Biomarkers of Endometrial Receptivity N/A
Completed NCT04297553 - Fresh Versus Freeze-only After CAPA IVM on PCOS Patients N/A
Completed NCT01846403 - Feasibility and Acceptability of Using the Semi-quantitative Pregnancy Test in an Assisted Fertility Setting N/A
Completed NCT02703181 - Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers Phase 1
Recruiting NCT02825290 - Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study Phase 4
Completed NCT01863680 - Phase 3 Trial to Evaluate the Efficacy and Safety of COL-1620 Vaginal Progesterone Gel Phase 3
Terminated NCT03386227 - Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT N/A
Recruiting NCT04124913 - Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles Phase 4
Completed NCT05364528 - Pregnancy Rate in Direct Versus Afterload Technique of Embryo Transfer
Completed NCT04253470 - Debate on Progesterone Elevation on the Day of Triggering
Completed NCT02257359 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers Phase 1
Not yet recruiting NCT06084793 - Music for Anxiety in Embryo Transfers N/A
Completed NCT03201783 - Immediate Versus Delayed FET Following a Stimulated IVF Cycle N/A
Recruiting NCT03518528 - Comparison of Vaginal and Transdermal Oestrogen Before Frozen Thawed Embryo Transfer